[HTML][HTML] Eslicarbazepine acetate: a new improvement on a classic drug family for the treatment of partial-onset seizures
GL Galiana, AC Gauthier, RH Mattson - Drugs in R&D, 2017 - Springer
Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
[引用][C] Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures
GL Galiana, AC Gauthier, RH Mattson - Drugs in R&D, 2017 - cir.nii.ac.jp
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of
Partial-Onset Seizures | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Partial-Onset Seizures | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures
GL Galiana, AC Gauthier, RH Mattson - Drugs in R and D, 2017 - pure.johnshopkins.edu
Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures.
GL Galiana, AC Gauthier, RH Mattson - Drugs in R&D, 2017 - search.ebscohost.com
Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures
GL Galiana, AC Gauthier, RH Mattson - Drugs in R&D, 2017 - pubmed.ncbi.nlm.nih.gov
Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
[HTML][HTML] Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures
GL Galiana, AC Gauthier, RH Mattson - Drugs in R&D, 2017 - ncbi.nlm.nih.gov
Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures.
GL Galiana, AC Gauthier, RH Mattson - Drugs in R&D, 2017 - europepmc.org
Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures
GL Galiana, AC Gauthier… - Drugs in R & D (Online), 2017 - search.proquest.com
Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures.
GL Galiana, AC Gauthier, RH Mattson - Drugs in R&D, 2017 - europepmc.org
Eslicarbazepine acetate is a new anti-epileptic drug belonging to the dibenzazepine
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …
carboxamide family that is currently approved as adjunctive therapy and monotherapy for …